Virtual Town Hall Series - Coronavirus (COVID-19) Test Development and Validation
March 9, 2022 –
The U.S. Food and Drug Administration (FDA) hosts regular virtual Town Halls for SARS-CoV-2 test developers. The purpose of these Town Halls is to help answer technical questions about the development and validation of tests for SARS-CoV-2. Registration is not necessary.
There will be an opportunity to ask questions live during the Town Halls, but questions may also be submitted in advance by emailing CDRHWebinars@fda.hhs.gov.
- Please submit questions by Monday 12 p.m. ET before to the Wednesday virtual Town Hall.
- In the subject line of the email, state "Question for the COVID-19 Test Virtual Town Hall"
Call Information:
The FDA will hold a virtual Town Hall for test developers from 12:15 p.m.-1:15 p.m. ET on:
- March 9, 2022: Town Hall 80
- March 23, 2022: Town Hall 81
- April 6, 2022: Town Hall 82
- April 20, 2022: Town Hall 83
Registration is not necessary.
Time: 12:15 p.m. - 1:15 p.m. ET
To ensure you are connected, please join 15 minutes before to the start of the virtual Town Hall at 12:00 p.m.
Please click the link below to join the webinar:
https://fda.zoomgov.com/j/1613459103?pwd=OTdiTnRBSldIVDROS1hqam0ydTZHQT09
Passcode: uw6%YD
Please note: Participants who join the virtual Town Hall using the Zoom webinar link above should use computer audio (listen through their computer speakers and speaking through computer microphone/headset).
The dial-in information provided below is for participants who will be joining the virtual Town Hall by phone only.
Dial: 669-254-5252
Webinar ID: 161 345 9103
Passcode: 696804
Following the webinar, a transcript, recording, and slides will be posted on the FDA's website along with the presentations/transcripts from previous town hall sessions.